In the search of glycogen phosphorylase inhibitors: 4. Synthesis of C-D-glycopyranosylbenzo(hydro)quinones - Inhibition of and binding to glycogen phosphorylase in the crystal

被引:32
作者
He, Li
Zhang, Yun Zhi
Tanoh, Marcelle
Chen, Guo-Rong
Praly, Jean-Pierre
Chrysina, Evangelia D.
Tiraidis, Costas
Kosmopoulou, Magda
Leonidas, Demetres D.
Oikonomakos, Nikos G.
机构
[1] Univ Lyon 1, CNRS, UMR 5181, UCBL,Lab Chim Organ 2, F-69622 Villeurbanne, France
[2] E China Univ Sci & Technol, Adv Mat Lab, Inst Fine Chem, Shanghai 200237, Peoples R China
[3] Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, GR-11635 Athens, Greece
关键词
C-glycosides; aromatic substitution; inhibitors; X-ray diffraction; glycogen phosphorylase;
D O I
10.1002/ejoc.200600548
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Penta-O-acetyl-beta-D-glycopyranoses and 1,4-dimethoxybenzene led selectively by electrophilic substitution to C-beta-D-glycopyranosyl-1,4-dimethoxybenzenes which were converted by simple and efficient reactions (oxidation, reduction and deacetylation) to the corresponding C-glycosylhydro- and C-glycosylbenzoquinones, with either an acetylated or deprotected sugar moiety. C-beta-D-Glucosylbenzoquinone 19 and C-beta-D-Glucosylhydroquinone 23 were found to be competitive inhibitors of rabbit muscle glycogen phosphorylase b (GPb), with respect to the substrate a-D-glucose-1-phosphate, with K-i values of 1.3 and 0.9 mm, respectively, whereas C-beta-D-glucosylhydroquinone 17 was not effective up to a concentration of 8 mm. In order to elucidate the structural basis of inhibition, we determined the crystal structures of 19 and 23 in complex with GPb at a 2.03-2.05 angstrom resolution. The complex structures reveal that the inhibitors can be accommodated at the catalytic site at approximately the same position as a-D-glucose and stabilise the transition state conformation of the 280s loop by making several favourable contacts to Asp283 and Asn284 of this loop. (C) Wiley-VCH Verlag GmbH & Co.
引用
收藏
页码:596 / 606
页数:11
相关论文
共 67 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Glycogen phosphorylase inhibition in type 2 diabetes therapy - A systematic evaluation of metabolic and functional effects in rat skeletal muscle [J].
Baker, DJ ;
Timmons, JA ;
Greenhaff, PL .
DIABETES, 2005, 54 (08) :2453-2459
[3]   Synthetic studies in the 5-thio-D-xylopyranose series part 2:: Coupling of 5-thio-D-xylopyranosyl donors with electron-rich aryl moieties:: Access to C-aryl 5-thio-D-xylopyranosides [J].
Baudry, M ;
Barberousse, V ;
Descotes, G ;
Pires, J ;
Praly, JP .
TETRAHEDRON, 1998, 54 (26) :7447-7456
[4]   Synthetic studies in the 5-thio-D-xylopyranose series -: part 3:: Preparations of O-phenyl and C-(4-hydroxyphenyl) 5-thio-D-xylopyranosides [J].
Baudry, M ;
Barberousse, V ;
Collette, Y ;
Descotes, G ;
Pires, J ;
Praly, JP ;
Samreth, S .
TETRAHEDRON, 1998, 54 (45) :13783-13792
[5]  
Beau JM, 1997, TOP CURR CHEM, V187, P1
[6]  
BELICA PS, 2005, ACS SYM SER, V896, P107
[7]  
Bertozzi C. R., 1996, MODERN METHODS CARBO, P316
[8]   GLYCOSYLIDENE CARBENES .2. SYNTHESIS OF O-ARYL GLYCOSIDES [J].
BRINER, K ;
VASELLA, A .
HELVETICA CHIMICA ACTA, 1990, 73 (06) :1764-1778
[9]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[10]  
Chrétien F, 1998, CARBOHYDRATE MIMICS, P143